Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
Researchers at Johns Hopkins found a single dose of psilocybin dramatically increased smoking cessation rates compared with nicotine patches. In a randomized trial of 82 smokers, 17 of 41 participants who received psilocybin remained abstinent after six months versus four of 41 on patches, a more than six‑fold advantage. All participants also received 13 weeks of cognitive‑behavioral therapy, and the study was published in JAMA Network Open. The authors note the need for larger, more diverse trials to confirm findings.
Scientists announced ETVAX, the first oral vaccine that targets enterotoxigenic *E. coli* (ETEC) in children, after a large‑scale trial in The Gambia. The study involved 4,936 infants aged six to 18 months and demonstrated a 48% reduction in moderate‑to‑severe ETEC...
Novo Nordisk received an FDA warning letter on March 5, 2026 for failing to report suspected side effects of its GLP‑1 medicines. The violations were uncovered during a 2025 inspection of the company’s facilities and were described as “serious.” The agency warned...
The Trump administration, led by Health Secretary Robert F. Kennedy Jr., plans to eliminate over a third of the CDC childhood vaccine schedule, targeting seven of eleven vaccines. The United States, which produces roughly 36% of global vaccine output, could...
Dubai is positioning itself as a long‑term hub for healthcare and life sciences through two complementary free‑zone clusters – Dubai Healthcare City (DHCC) and Dubai Science Park (DSP). DHCC is undergoing a $1.3 bn expansion that will create six tightly linked...
Smith+Nephhew has introduced ALLEVYN ♢ COMPLETE CARE, a next‑generation five‑layer foam dressing that combines wound‑management and pressure‑injury prevention technologies. The dressing locks in significantly more exudate than competing foams, blocks over 99% of bacteria, and absorbs up to 93% of mechanical energy...
Validic announced a new integration with Salesforce Health Cloud at HIMSS 2026, linking its remote patient monitoring and wearable data platform to the cloud‑based patient engagement system. The partnership delivers HIPAA‑compliant, real‑time device data directly into Health Cloud’s 360‑degree patient...
Facing steep foreign‑aid cuts and high sovereign debt, Africa CDC is turning to debt‑for‑health swaps to bridge financing gaps. The agency has hired Christoph Benn, a veteran of the Global Fund’s Debt2Health mechanism, to spearhead matchmaking between debtor nations and...
The FDA has defined the scope of pre‑submission facility meetings to curb manufacturing‑related complete response letters that delay drug approvals. It agreed to cover prior production‑site inspections, novel process elements and supply‑chain node strategies, while rejecting topics such as alternative...
Betterness unveiled the Betterness Model Context Protocol (MCP), an agentic infrastructure that lets AI systems coordinate diagnostics, biomarker data, wearable signals, and provider networks. The protocol integrates with major lab partners such as Quest Diagnostics, LabCorp, and BioReference, and offers...
A bipartisan call in Washington urges the United States to make curing Alzheimer’s a flagship scientific enterprise. The proposal calls for billions in basic brain research, Medicare coverage for early diagnosis and preventive treatment starting at age 50, and parity...
On the latest episode of Lifers, I’m joined by @MSFTResearch President @peteratmsr. We dive into the evolution of AI and his bold predictions for the future of healthcare. Timestamps: (00:00) Preview (01:23) Intro (02:54) Evolution from deep neural nets to modern AI (04:30) Demystifying model...
Arizona's biotech sector is booming, with $3.7 billion invested over the past seven years and a growing pipeline of innovative companies. Nectero Therapeutics secured a $96 million Series D to develop a fast‑track, breakthrough‑designated endovascular treatment for abdominal aortic aneurysms, while Humabiologics obtained...
Polypharmacy affects nearly 42 % of adults 65 + taking five or more drugs, with 12 % on ten or more, driving higher pharmacy spend and safety risks. Medicare patients alone incurred about $3 billion in excess drug costs from early refills and oversupply,...
Federal judge Donald Middlebrooks ruled that The Leapfrog Group must remove the safety grades it assigned to five Tenet Healthcare hospitals, finding the ratings deceptive and unfair. The grades, which were based on an alternative scoring system after the hospitals...
The ALS Functional Rating Scale‑Revised (ALSFRS‑R) remains the primary tool for tracking disease progression, but its limited granularity misses daily fluctuations and subtle improvements. Caregivers, like the author, become the sole recorders of these nuanced changes, highlighting a critical data...
This morning's BioNTech news strikes me as very odd. Certainly, founder Ugur Sahin and Ozlem Tureci shouldn't feel compelled to run the company forever, and they may not be the right people to manage both the continued decline of Covid-19...
Insightin Health disclosed a March 4 2026 breach that stemmed from a zero‑day flaw in the GoAnywhere file‑transfer tool, allowing an unauthorized actor to access health‑plan data between September 17‑23 2025. The compromised files contained member names, dates of birth, insurance IDs and, in...
Early‑stage life sciences firms face unique valuation challenges due to regulatory, market and scientific uncertainties. Traditional discounted cash flow models are unsuitable, so practitioners rely on risk‑adjusted NPV, market comparables, and venture‑capital exit methods. These valuations influence capital raising, stock‑based...
Mercy Hospital in Moundridge, Kansas, converted to a Rural Emergency Hospital (REH) on Jan. 1, 2024, swapping inpatient services for 24‑hour emergency care and outpatient offerings. The REH model provides a $3.4 million annual facility payment and 105% of the OPPS rate,...
The Grapevine Professional Firefighters Association is challenging the city’s plan to close Engine 1 and replace it with a two‑person squad, arguing the move undermines fire‑suppression capacity. The union cites a 19.8% rise in total emergency calls and a 13.1% increase...
Deaminet 2026 showcased accelerating advances in base and prime editing, highlighted by rapid Addgene distribution growth and new mechanistic insights such as PE6d’s heightened processivity and ABE8e’s dimer‑driven efficiency. Novel off‑target detection platforms like beCasKAS and Inrich‑seq revealed far more unintended...
Sticking with the science. I find that really impressive. BioNTech founders Uğur Şahin and Özlem Türeci are leaving the biotech they founded to start a new one. Maybe by the time they have something for the clinic, the FDA will...
Former senior midwife Donna Ockenden has been appointed chair of an independent review into Leeds Teaching Hospitals' maternity services, following intense lobbying by bereaved families and MPs. The inquiry, approved by Health Secretary Wes Streeting, will examine care, governance and...
China is actively targeting ultra‑expensive gene therapies, challenging the notion that these treatments are immune to price competition. Recent regulatory approvals and centralized procurement initiatives have forced manufacturers to negotiate steep discounts on therapies that once commanded multi‑million‑dollar price tags....
The Nottingham City Place‑Based Partnership is rolling out neighbourhood‑focused preventive health services to align with the NHS 10‑Year Plan. By deploying free SISU Health Stations in community hubs such as a deprived suburb, a Boots store and a football fan...
The U.S. Food and Drug Administration has approved the generic form of leucovorin, also known as folinic acid, for treating cerebral folate deficiency (CFD). The decision widens the drug’s label despite the absence of new clinical trial data, relying on...
Sam Shainberg’s short film “Endless Sea” follows Carol, a flower‑delivery worker, as she scrambles to pay a $365 co‑pay for life‑saving heart medication, exposing the harsh reality of tiered prescription pricing. Set on a rainy Valentine’s Day, the 17‑minute thriller...
BIOTECanada welcomes the launch of the National Research Council of Canada’s Biomedical Countermeasures Initiative, a key component of the federal Defence Industrial Strategy. The program is designed to strengthen Canada’s domestic capacity to develop and manufacture diagnostics, vaccines, and therapeutics...
The United States faces a critical shortage of physician assistants, with only 56 per 100,000 residents nationally and just 36 in California. Universities are stepping in by partnering with regional health systems to create pipeline programs that train PAs directly...
Cardiac amyloidosis affects up to a quarter of people over 80 yet remains largely undiagnosed. Characteristic echocardiographic signs—including thickened walls, restrictive filling patterns, and the apical‑sparing strain signature—allow clinicians to suspect the disease early. Differentiating the three amyloid subtypes on...
Every week, I track the signals that show where medicine is really going from the latest AI breakthroughs and digital health tools to the cultural shifts redefining patient care. The Medical Futurist Newsletter brings you: ✅ Curated insights on the most impactful...
3 new reports and an editorial @NatureCancer reinforce the benefit of AI for breast cancer screening https://t.co/MlFns7M0yB https://t.co/MF3fj0CuIE https://t.co/a436srKDaD https://t.co/1XTMIsAPfg
Stylus Medicine entered the cell‑therapy arena in May 2025 with an in‑vivo CAR‑T platform that delivers a lipid nanoparticle‑encapsulated recombinase to engineer T cells inside patients. The move comes after major pharma acquisitions—BMS buying Orbital Therapeutics for $1.5 billion and Gilead...
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma https://t.co/v39bOreJwu
Correction: I took down a post about Thursday's #VRBPAC meeting because it contained an error. #FDA has named 6 temporary voting members (not 2), which will bring the number for the meeting to 9. The temps are all former members....
:max_bytes(150000):strip_icc():format(jpeg)/TAL-vermont-STS4SENIORS0226-f6327204c50b420b868bffdf12e7c63c.jpg)
Opera Beds released a new study ranking U.S. states by senior health and well‑being, using America’s Health Rankings data from 2015‑2025. Vermont topped the list with the lowest diabetes rate (16.7%) and below‑average obesity, while Hawaii and Colorado followed thanks to...
$CAPR resubmission of the deramiocel application accepted by the FDA. New decision date: Aug. 22. https://t.co/mWSyyXg8di
How CRISPR works (in nature) and how it’s being leveraged as a tool for gene editing to cure and prevent diseases. Dr Alex Marson MD PhD of UCSF on the Huberman Lab podcast out now. https://t.co/fiL48JHxSL
Lundbeck has promoted Markus Kede to chief AI officer, shifting him from finance to lead the drugmaker's AI agenda. The newly created role reports directly to CEO Charl van Zyl and will be based in Sweden. Kede will oversee AI...
“Overpayments to Medicare Advantage insurers increased Part B premiums by $13.4 billion in 2025, the committee said, a cost mostly borne by seniors.”
$GSK is ostensibly the "sponsor" that won the approval but is once again saying it won't produce the drug.
A twelve‑week randomized, double‑blind trial found that daily supplementation with 14 g arginine and 6 g fish oil improved gait speed, hand‑grip strength, and functional activity scores in older adults with sarcopenia. The intervention also lowered inflammatory markers (TNF‑α, IL‑6) and triglyceride...
The Femtech Company of the Year award, sponsored by Cross‑Border Impact Ventures (CBIV), seeks to elevate firms that are reshaping women’s health through technology. It recognizes companies tackling reproductive health, maternal care, menopause and related gaps, rewarding exceptional impact and...
U.S. pharmaceutical manufacturing is booming, with companies pledging over $370 billion in new facilities through 2030, prompting senior executives to relocate to the United States. At the same time, U.S. academic and research funding has been slashed, leading a majority of...
New research using a general‑equilibrium model for Tanzania shows that a nationwide malaria vaccination program with 75% efficacy could lift per‑capita income by 5.2% in the short run and up to 6.7% over generations—five times larger than earlier estimates. The...
French biotech Ipsen announced an immediate, global voluntary withdrawal of its oncology drug tazemetostat (Tazverik) after safety signals in the SYMPHONY‑1 confirmatory trial indicated a rise in secondary hematologic malignancies. The company is coordinating with the FDA to manage the...
ControlUp has launched Tap-to-App, the industry’s first clinician‑centric tool that delivers end‑to‑end visibility of login experiences on shared hospital workstations. The capability is built exclusively for IGEL OS and links badge‑tap events with virtual desktop and application layers to show...
The blog post contends that puberty‑blocking drugs such as Lupron cause irreversible damage, highlighting a social‑media case of jaw deterioration and enamel loss. It asserts that these medications lead to permanent bone mineral density loss and lifelong health risks, framing...
Large language models are increasingly embedded in clinical documentation, patient chatbots, and medical education, but a new Lancet Digital Health study reveals they can still repeat or partially accept false medical claims. Researchers tested leading models with misinformation‑laden prompts and...
